Dua Asim: Efficacy and Safety of Rivaroxaban Plus Aspirin in PAD Patients
Dua Asim, Third-Year Medical Student at Jinnah Sindh Medical University, shared a post on LinkedIn about a recent article she and her colleagues co-authores, published in Annals of Medicine and Surgery, adding:
“I am pleased to share our recently published systematic review and meta-analysis, ‘Efficacy and Safety of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in Patients with Peripheral Arterial Disease,’ published in Annals of Medicine and Surgery.
This study evaluates dual pathway inhibition using rivaroxaban plus aspirin in patients with peripheral arterial disease.
Our findings suggest that combination therapy may improve cardiovascular and limb-related outcomes; however, it also underscores the importance of careful, individualized risk assessment due to an increased risk of major bleeding.
I am sincerely grateful to my co-authors for their dedication, collaboration, and valuable contributions to this work.”
Title: Efficacy and safety of rivaroxaban plus aspirin compared with aspirin alone in patients with peripheral arterial disease: a systematic review and meta-analysis
Authors: Muhammad Farhan, Syed Hassan Ali, Daniyal Khalid, Adina Kazmi, Dua Asim, Zoha Idrees, Muhammad Saim Siddiqui, Sudais Bin Sohaib, Muhammad Saad Khan, Muhammad Mohsin Khan, Abubakr Mahmoud

Stay updated with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering